Elements of Th1/Th2 response and disease severity in COVID-19 patients : A short report
© 2021 Wiley Periodicals LLC..
The presence of a complex immune dysregulation syndrome has been established in COVID-19 patients. We aimed to assess Th1/Th2 response in COVID-19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID-19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin-6 (IL-6) and IL-10. Future larger studies should examine lung-specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
Journal of medical virology - 94(2022), 1 vom: 01. Jan., Seite 404-406 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Akinosoglou, Karolina [VerfasserIn] |
---|
Links: |
---|
Themen: |
130068-27-8 |
---|
Anmerkungen: |
Date Completed 23.11.2021 Date Revised 11.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jmv.27313 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330029207 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330029207 | ||
003 | DE-627 | ||
005 | 20231225210418.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jmv.27313 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330029207 | ||
035 | |a (NLM)34460125 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Akinosoglou, Karolina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Elements of Th1/Th2 response and disease severity in COVID-19 patients |b A short report |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.11.2021 | ||
500 | |a Date Revised 11.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Wiley Periodicals LLC. | ||
520 | |a The presence of a complex immune dysregulation syndrome has been established in COVID-19 patients. We aimed to assess Th1/Th2 response in COVID-19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID-19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin-6 (IL-6) and IL-10. Future larger studies should examine lung-specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Th1/Th2 response | |
650 | 4 | |a inflammation | |
650 | 7 | |a IL10 protein, human |2 NLM | |
650 | 7 | |a IL6 protein, human |2 NLM | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Interleukin-10 |2 NLM | |
650 | 7 | |a 130068-27-8 |2 NLM | |
700 | 1 | |a Delastic, Anne-Lise |e verfasserin |4 aut | |
700 | 1 | |a Dimakopoulou, Vasilina |e verfasserin |4 aut | |
700 | 1 | |a Marangos, Markos |e verfasserin |4 aut | |
700 | 1 | |a Gogos, Charalambos |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 94(2022), 1 vom: 01. Jan., Seite 404-406 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2022 |g number:1 |g day:01 |g month:01 |g pages:404-406 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.27313 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 94 |j 2022 |e 1 |b 01 |c 01 |h 404-406 |